Irish Life Investment Managers’s Aegerion Pharmaceuticals AEGR Stock Holding History

Irish Life Investment Managers’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$82.3K	Buy	+1,300	New	+$69K	﹤0.01%	1038

Other funds holding AEGR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Irish Life Investment Managers's AEGR Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Aegerion Pharmaceuticals (AEGR) in Q2 2013: 1,300 shares worth $82.3K. The stake represents ﹤0.01% of the portfolio and ranks #1038 among its holdings.

145 funds tracked by Wall St. Rank hold AEGR as of Q2 2013.

Irish Life Investment Managers held 1,300 shares of Aegerion Pharmaceuticals worth $82.3K as of Q2 2013.
Aegerion Pharmaceuticals was a new Irish Life Investment Managers position in Q2 2013.
Aegerion Pharmaceuticals made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1038 holding.
145 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.